Patents by Inventor Stephan WULLSCHLEGER

Stephan WULLSCHLEGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1
    Publication number: 20240216471
    Abstract: The present invention relates to the combination therapy of specific PD-1-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1.
    Type: Application
    Filed: November 21, 2023
    Publication date: July 4, 2024
    Inventors: Laura CODARRI DEAK, Douglas HANAHAN, Christian KLEIN, Valeria NICOLINI, Pablo UMANA, Stephan WULLSCHLEGER
  • Combination therapy of PD-1-targeted IL-2 variant immunocytokines and antibodies against human PD-L1
    Patent number: 11865082
    Abstract: The present invention relates to the combination therapy of specific PD-1-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: January 9, 2024
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Laura Codarri Deak, Douglas Hanahan, Christian Klein, Valeria Nicolini, Pablo Umana, Stephan Wullschleger
  • SYSTEM FOR OFFLINE PAYMENT WITH E-MONEY USING A MOBILE DEVICE WITH A SHORT TRANSACTION TIME AND FINAL SETTLEMENT
    Publication number: 20190347626
    Abstract: A system for secure payment with electronic money using a mobile device, in particular using a non-secure mobile device (2) without a suitable security element, to the electronic money. In addition is a method for secure payment with electronic money as well as to the use of the method.
    Type: Application
    Filed: December 15, 2017
    Publication date: November 14, 2019
    Applicant: PBV KAUFMANN SYSTEME GMBH
    Inventors: Stephan WULLSCHLEGER, Markus KNECHT, Dominik GRUNTZ, Christof ARNOSTI